rc148
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 14, 2023 (NCT06016062)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06883630 | Phase 1 | Mar 13, 2025 | RemeGen, Sun Yat-Sen University |
| NCT06642545 | Phase 2 | Nov 1, 2024 | RemeGen |
| NCT06016062 | Phase 1 | Sep 14, 2023 | RemeGen |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| RemeGen | For profit | 3 | 3 | 2 | 2023 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1